Feasibility and Optimal Time Point of [(68)Ga]Gallium-labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography Imaging in Patients Undergoing Cytoreductive Surgery After Systemic Therapy for Primary Oligometastatic Prostate Cancer: Implications for Patient Selection and Extent of Surgery

BACKGROUND: Prostate-specific membrane antigen (PSMA) targeted molecular imaging using positron emission tomography (PET) has significantly improved the diagnosis and treatment of prostate cancer (PCA). OBJECTIVE: To assess the feasibility and compare the diagnostic accuracy of [(68)Ga]Ga-PSMA-11 PE...

Descripción completa

Detalles Bibliográficos
Autores principales: Huebner, Nicolai, Rasul, Sazan, Baltzer, Pascal, Clauser, Paola, Hermann Grubmüller, Karl, Mitterhauser, Markus, Hacker, Marcus, Heidenreich, Axel, Rajwa, Pawel, Fajkovic, Harun, Shariat, Shahrokh F., Grubmüller, Bernhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Prostate Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142741/
https://www.ncbi.nlm.nih.gov/pubmed/35638090
http://dx.doi.org/10.1016/j.euros.2022.04.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142741/
https://www.ncbi.nlm.nih.gov/pubmed/35638090
http://dx.doi.org/10.1016/j.euros.2022.04.003

Ejemplares similares